A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. - Ganly,I.; Kirn,D.; Eckhardt,G.; Rodriguez,G.I.; Soutar,D.S.; Otto,R.; Robertson,A.G.; Park,O.; Gulley,M.L.; Heise,C.; Von Hoff,D.D.; Kaye,S.B. (Clin Cancer Res, 2000)